Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 1 3Phase 3 2Phase 2 2Phase 1/2 2Phase 4 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Genitourinary 1Dermatologic 1

Conditions

Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Hypertension 1Gastrointestinal Neoplasms 1Fibrosis 1Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 218Fluorouracil 142Oxaliplatin 132Capecitabine 122pembrolizumab 114Irinotecan 110Leucovorin 104Bevacizumab 98Cisplatin 81Nivolumab 80130-nm albumin-bound paclitaxel 80Cetuximab 79Radiotherapy 78Albumin-Bound Paclitaxel 59Sorafenib 56Paclitaxel 53Cyclophosphamide 50Carboplatin 48Magnetic Resonance Spectroscopy 44Specimen Handling 39Docetaxel 37Taxes 36fludarabine 34Radiation 34durvalumab 33Ipilimumab 33Erlotinib Hydrochloride 33Biopsy 33Radiosurgery 27Folfox protocol 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Vitamin D × Gastrointestinal × Clear all
NCT03883919 2022-10-05

Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy

Washington University School of Medicine

Phase 1 Completed
20 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01956864 2018-02-01

Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer

Johns Hopkins University

Phase 1 Withdrawn
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT00585637 2015-04-01

Vitamin D for Chemoprevention

Dana-Farber Cancer Institute

Phase 1 Completed
328 enrolled 11 charts
GastrointestinalGenitourinary

Gastrointestinal Neoplasms, Hypertension, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡